JOHNSON & JOHNSON is 160.6x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($579.83 B vs $3.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACAD | JNJ |
|---|---|---|
| Market cap | $3.61 B | $579.83 B |
| US-listed rank | #1674 | #20 |
| Revenue (latest FY) | $1.07B | $94.19B |
| Net income (latest FY) | $391.00M | $26.80B |
| Net margin | 36.5% | 28.5% |
| P/E (trailing FY) | 9.2 | 21.6 |
| SEC filings | 1,357 | 984 |
JOHNSON & JOHNSON is 160.6x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($579.83 B vs $3.61 B).
In their latest fiscal years, ACADIA PHARMACEUTICALS INC reported $1.07B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: ACADIA PHARMACEUTICALS INC and JOHNSON & JOHNSON, or browse the full rankings.